CL2015003004A1 - Forma de dosificación de película que contiene base libre de tadalafilo que contiene polímero con base de polietilenglicol y/o polímero con base de povidona como estabilizante de dispersión - Google Patents

Forma de dosificación de película que contiene base libre de tadalafilo que contiene polímero con base de polietilenglicol y/o polímero con base de povidona como estabilizante de dispersión

Info

Publication number
CL2015003004A1
CL2015003004A1 CL2015003004A CL2015003004A CL2015003004A1 CL 2015003004 A1 CL2015003004 A1 CL 2015003004A1 CL 2015003004 A CL2015003004 A CL 2015003004A CL 2015003004 A CL2015003004 A CL 2015003004A CL 2015003004 A1 CL2015003004 A1 CL 2015003004A1
Authority
CL
Chile
Prior art keywords
based polymer
polyethylene glycol
dosage form
free base
dispersion stabilizer
Prior art date
Application number
CL2015003004A
Other languages
English (en)
Inventor
Hong Ryeol Jeon
Do-Woo Kwon
Bong-Sang Lee
Su-Jun Park
Bong-Geun Cha
Jun-Ki Kim
Jiyeong Han
Myeongcheol Kil
Original Assignee
Ctc Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51689788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015003004(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ctc Bio Inc filed Critical Ctc Bio Inc
Publication of CL2015003004A1 publication Critical patent/CL2015003004A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
CL2015003004A 2013-04-11 2015-10-08 Forma de dosificación de película que contiene base libre de tadalafilo que contiene polímero con base de polietilenglicol y/o polímero con base de povidona como estabilizante de dispersión CL2015003004A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20130040084 2013-04-11

Publications (1)

Publication Number Publication Date
CL2015003004A1 true CL2015003004A1 (es) 2016-05-13

Family

ID=51689788

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015003004A CL2015003004A1 (es) 2013-04-11 2015-10-08 Forma de dosificación de película que contiene base libre de tadalafilo que contiene polímero con base de polietilenglicol y/o polímero con base de povidona como estabilizante de dispersión

Country Status (15)

Country Link
US (2) US20160074396A1 (es)
EP (1) EP2985020B1 (es)
JP (1) JP6470257B2 (es)
KR (1) KR102223105B1 (es)
CN (1) CN105209025B (es)
AP (1) AP2015008840A0 (es)
AU (1) AU2014251532B2 (es)
BR (1) BR112015025859A2 (es)
CL (1) CL2015003004A1 (es)
EA (1) EA033893B1 (es)
MX (1) MX2015013840A (es)
MY (1) MY173159A (es)
SG (1) SG11201508391SA (es)
WO (1) WO2014168455A1 (es)
ZA (1) ZA201508272B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101538985B1 (ko) * 2014-09-02 2015-07-24 주식회사 서울제약 타다라필 구강붕해필름 및 이의 제조방법
KR101634382B1 (ko) 2015-10-20 2016-06-28 미래제약 주식회사 타다라필 경구용 액제
CN106176685A (zh) * 2016-07-29 2016-12-07 齐鲁制药有限公司 一种包含他达拉非的口溶膜剂及其制备方法
CZ2017781A3 (cs) * 2017-12-05 2019-06-12 Zentiva, K.S. Těžko rozpustné terapeutická činidla,která patřící do BCS skupiny II nebo IV, suspendovaná v kapalné formulaci a/nebo v konečné nanovláknité struktuře
EP3749370A1 (de) * 2018-02-07 2020-12-16 Smawa GmbH Pharmazeutische formulierungen, verfahren zum herstellen einer pharmazeutischen formulierung sowie ein arzneimittel umfassend eine solche
US10828254B2 (en) * 2018-09-28 2020-11-10 Intelgenx Corp. Oral film formulation for modulating absorption profile
KR102110179B1 (ko) 2019-07-18 2020-05-13 주식회사 서울제약 타다라필 또는 그의 약제학적으로 허용되는 염 함유 구강붕해필름

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2435816T3 (es) 1999-08-03 2013-12-23 Icos Corporation Formulación farmacéutica que comprende una Beta-carbolina y su uso para el tratamiento de la disfunción sexual
US6821975B1 (en) 1999-08-03 2004-11-23 Lilly Icos Llc Beta-carboline drug products
CA2473967C (en) * 2001-10-12 2011-06-14 Monosolrx Llc Thin film with non-self-aggregating uniform heterogeneity, process for their production and drug delivery systems made therefrom
AR051397A1 (es) * 2004-10-21 2007-01-10 Novartis Ag Composicion farmaceutica
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
US20070104792A1 (en) * 2005-09-13 2007-05-10 Elan Pharma International, Limited Nanoparticulate tadalafil formulations
GB0607105D0 (en) * 2006-04-10 2006-05-17 Leuven K U Res & Dev Enhancing solubility and dissolution rate of poorly soluble drugs
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
KR100855566B1 (ko) * 2006-09-12 2008-09-03 (주) 아모젠 경구용 소모성 필름
DE102007028869A1 (de) * 2007-06-22 2008-12-24 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
US20090047330A1 (en) * 2007-08-17 2009-02-19 Ramesh Bangalore Oral fast dissolving films for erectile dysfunction bioactive agents
EP2326638B9 (en) * 2008-08-06 2013-11-13 Pfizer Limited Diazepine and diazocane compounds as mc4 agonists
KR101074271B1 (ko) * 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
KR20110041412A (ko) * 2009-10-15 2011-04-21 (주)씨엘팜 Pde5 억제제를 함유하는 구강 용해성 필름
US20110136815A1 (en) * 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US20110263606A1 (en) * 2010-04-26 2011-10-27 Horst Zerbe Solid oral dosage forms comprising tadalafil
WO2012053006A2 (en) * 2010-10-18 2012-04-26 Panacea Biotec Ltd Improved oral fast dissolving films comprising combination of polymers and method of preparation thereof
CN103402504B (zh) * 2011-02-11 2015-10-14 西梯茜生命工学股份有限公司 包含西地那非游离碱的膜制剂及其生产方法
KR101303479B1 (ko) * 2011-07-28 2013-09-06 (주)씨엘팜 가식성 필름형성 조성물 및 약물이 함유된 가식성 필름형 제제
US20150202168A1 (en) * 2012-08-17 2015-07-23 Sanovel llac Sanayi Ve Ticaret Anonim Sirketi Oral film formulations comprising dapoxetine and tadalafil
CN102824333B (zh) * 2012-09-26 2014-05-14 苏州大学 一种口腔速溶膜剂及其制备方法

Also Published As

Publication number Publication date
AU2014251532B2 (en) 2019-05-23
KR20140123027A (ko) 2014-10-21
ZA201508272B (en) 2018-05-30
EP2985020B1 (en) 2021-06-23
US20160074396A1 (en) 2016-03-17
WO2014168455A1 (ko) 2014-10-16
EP2985020A4 (en) 2016-10-12
EA201591950A1 (ru) 2016-04-29
MY173159A (en) 2019-12-31
SG11201508391SA (en) 2015-11-27
MX2015013840A (es) 2016-06-02
AP2015008840A0 (en) 2015-11-30
US20200085818A1 (en) 2020-03-19
JP2016516784A (ja) 2016-06-09
EP2985020A1 (en) 2016-02-17
BR112015025859A2 (pt) 2017-07-25
EA033893B1 (ru) 2019-12-06
KR102223105B1 (ko) 2021-03-04
JP6470257B2 (ja) 2019-02-13
CN105209025B (zh) 2019-06-18
CN105209025A (zh) 2015-12-30
AU2014251532A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
CL2015003004A1 (es) Forma de dosificación de película que contiene base libre de tadalafilo que contiene polímero con base de polietilenglicol y/o polímero con base de povidona como estabilizante de dispersión
DK2984138T3 (da) Polymersammensætning
CL2015003240A1 (es) Polimero de polietileno de alta densidad
BR112016005768A2 (pt) películas de polímero
DK3071223T3 (da) Cell
EP2982712A4 (en) ANTISTATIC HARDENABLE ORGANOPOLYSILOXANE COMPOSITION AND ANTISTATIC SILICONE FILM
EP2949692A4 (en) FILM OF PLASTIC MATERIAL
DK2973606T3 (da) Implanterbar elektrode omfattende en ledende polymercoating
DE202014011212U8 (de) Superabsorberpolymerzusammensetzung
CL2014000864S1 (es) Envase de medicamento
CL2014000866S1 (es) Envase de medicamento
EP2985324A4 (en) FOIL WITH COPOLYMER OR COMPOSITION
CL2016001382A1 (es) Estabilidad de gel mejorada
DK3344663T3 (da) Penflufenhholdige polymerpartikler
SG11201506544UA (en) Biaxially-stretched film and ethylene polymer composition
DK3065679T3 (da) Beholder
EP2949690A4 (en) PLASTIC FILM
ES2640822T8 (es) Composición de resina y artículo moldeado
FR3007291B1 (fr) Composition cicatrisante et utlisation
EP3015520A4 (en) POLYMER FILM
DE112014004791A5 (de) Hochwasserschutz
ES1098586Y (es) Contenedor y bandeja forestal
TH1501000981B (th) พอลิเมอร์ที่มีเอธิลีนเป็นพื้นฐาน และชิ้นวัตถุที่ทำจากสิ่งนั้น
UA25228S (uk) Каністра полімерна
TH1501001024B (th) ฟิล์มกลุ่มโพลีเอสเตอร์ที่หดตัวด้วยความร้อน